View Item 

Show simple item record

Design of high affinity cyclic pentapeptide ligands for Κ-opioid receptors

dc.contributor.authorPrzydzial, M. J.en_US
dc.contributor.authorPogozheva, Irina D.en_US
dc.contributor.authorHo, Jeffrey C.en_US
dc.contributor.authorBosse, Kelly E.en_US
dc.contributor.authorSawyer, E.en_US
dc.contributor.authorTraynor, John R.en_US
dc.contributor.authorMosberg, Henry I.en_US
dc.date.accessioned2010-06-01T20:11:49Z
dc.date.available2010-06-01T20:11:49Z
dc.date.issued2005-11en_US
dc.identifier.citationPrzydzial, M.J.; Pogozheva, I.D.; Ho, J.C.; Bosse, K.E.; Sawyer, E.; Traynor, J.R.; Mosberg, H.I. (2005). "Design of high affinity cyclic pentapeptide ligands for Κ-opioid receptors." The Journal of Peptide Research 66(5): 255-262. <http://hdl.handle.net/2027.42/73319>en_US
dc.identifier.issn1397-002Xen_US
dc.identifier.issn1399-3011en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73319
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16218993&dopt=citationen_US
dc.format.extent266493 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2005 Blackwell Munksgaarden_US
dc.subject.othercyclic peptidesen_US
dc.subject.otherG protein-coupled receptoren_US
dc.subject.otherΚ -opioid receptoren_US
dc.subject.otheropioid ligandsen_US
dc.titleDesign of high affinity cyclic pentapeptide ligands for Κ-opioid receptorsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid16218993en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73319/1/j.1399-3011.2005.00295.x.pdf
dc.identifier.doi10.1111/j.1399-3011.2005.00295.xen_US
dc.identifier.sourceThe Journal of Peptide Researchen_US
dc.identifier.citedreferenceEvans, C.J., Keith, D.E. Jr, Morrison, H., Magendzo, K. & Edwards, R.H. ( 1992 ) Cloning of a delta opioid receptor by functional expression. Science 258, 1952 – 1955.en_US
dc.identifier.citedreferenceKieffer, B.L., Befort, K., Gaveriaux-Ruff, C. & Hirth, C.G. ( 1992 ) The delta opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl Acad. Sci. U S A 89, 12048 – 12052.en_US
dc.identifier.citedreferenceChen, Y., Mestek, A., Liu, J. & Yu, L. ( 1993 ) Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem. J. 295, 625 – 628.en_US
dc.identifier.citedreferenceWang, J.B., Imai, Y., Eppler, C.M., Gregor, P., Spivak, C.E. & Uhl, G.R. ( 1993 ) Mu opiate receptor: cDNA cloning and expression. Proc. Natl Acad. Sci. U S A 90, 10230 – 10234.en_US
dc.identifier.citedreferenceThompson, R.C., Mansour, A., Akil, H. & Watson, S.J. ( 1993 ) Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 11, 903 – 913.en_US
dc.identifier.citedreferenceYasuda, K., Raynor, K., Kong, H., Breder, C.D., Takeda, J., Reisine, T. & Bell, G.I. ( 1993 ) Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl Acad. Sci. U S A 90, 6736 – 6740.en_US
dc.identifier.citedreferenceMeng, F., Xie, G.X., Thompson, R.C., Mansour, A., Goldstein, A., Watson, S.J. & Akil, H. ( 1993 ) Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl Acad. Sci. U S A 90, 9954 – 9958.en_US
dc.identifier.citedreferenceMinami, M., Toya, T., Katao, Y., Maekawa, K., Nakamura, S., Onogi, T., Kaneko, S. & Satoh, M. ( 1993 ) Cloning and expression of a cDNA for the rat kappa opioid receptor. FEBS Lett. 329, 291 – 295.en_US
dc.identifier.citedreferenceMosberg, H.I. & Fowler, C.B. ( 2002 ) Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs. delta selectivity. J. Pept. Res. 60, 329 – 335.en_US
dc.identifier.citedreferenceFowler, C.B., Pogozheva, I.D., Lomize, A.L., LeVine, H. III & Mosberg, H.I. ( 2004 ) Complex of and active mu opioid receptor with cyclic peptide agonist modeled from experimental constraints. Biochemistry 43, 15796 – 15810.en_US
dc.identifier.citedreferenceMagnan, J., Paterson, S.J. & Kosterlitz, H.W. ( 1982 ) The interaction of [MET5]enkephalin and [LEU5]enkephalin sequences, extended at the C-terminus, with the mu-, delta- and kappa-binding sites in the guinea-pig brain. Life Sci. 31, 1359 – 1361.en_US
dc.identifier.citedreferenceChavkin, C. & Goldstein, A. ( 1981 ) Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl Acad. Sci. U S A 78, 6543 – 6547.en_US
dc.identifier.citedreferenceSnyder, K.R., Story, S.C., Heidt, M.E., Murray, T.F., DeLander, G.E. & Aldrich, J.V. ( 1992 ) Effect of modification of the basic residues of dynorphin A-(1–13) amide on kappa opioid receptor selectivity and opioid activity. J. Med. Chem. 35, 4330 – 4333.en_US
dc.identifier.citedreferenceVig, B.S., Murray, T.F. & Aldrich, J.V. ( 2004 ) Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1–11) amide analogs cyclized between positions 2 and 5: 1. Substitutions in position 3. J. Med. Chem. 47, 446 – 455.en_US
dc.identifier.citedreferencePrzydzial, M.J., Pogozheva, I.D., Andrews, S.M., Tharp, T.A., Drankhan, K.E., Traynor, J.R. & Mosberg, H.I. ( 2005 ) Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptor. J. Pept. Res. 65, 333 – 342.en_US
dc.identifier.citedreferenceHusbands, S.M., Neilan, C.L., Broadbear, J., Grundt, P., Breeden, S., Aceto, M.D., Woods, J.H., Lewis, J.W. & Traynor, J.R. ( 2005 ) BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. Eur. J Pharmacol. 509, 117 – 125.en_US
dc.identifier.citedreferenceLee, K., Akil, H., Woods, J.H. & Traynor, J.R. ( 1999 ) Novel binding properties of oripavines at a cloned mu opioid receptor. Eur. J. Pharmacol. 378, 323 – 330.en_US
dc.identifier.citedreferenceGÜntert, P., Brawn, W. & WÜthrich, K. ( 1991 ) Efficient computation of three-dimensional protein structure in solution from NMR data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. J. Mol. Biol. 21, 517 – 530.en_US
dc.identifier.citedreferenceLi, J., Edwards, P.C., Burghammer, M., Villa, C. & Schertler, G.F. ( 2004 ) Structure of bovine rhodopsin in a trigonal crystal form. J. Mol. Biol. 343, 1409 – 1438.en_US
dc.identifier.citedreferenceCollins, N., Flippen-Andersen, J.L., Haaseth, R.C., Deschamps, J.R., George, C., KÖvÉr, K. & Hruby, V.J. ( 1996 ) Conformational determinants of agonist versus antagonist properties of [D-Pen 2,D-Pen 5 ]enkephalin (DPDPE) analogs at opioid receptors. Comparison of X-ray crystallographic structure, solution 1 H NMR data, and molecular dynamic simulation of [L-Ala 3 ]DPDPE and [D-Ala 3 ]DPDPE J. Am. Chem. Soc 118, 2143 – 2152.en_US
dc.identifier.citedreferencePogozheva, I.D., Przydzial, M.J. & Mosberg, H.I. ( 2005 ) Homology modeling of opioid receptor-ligand complexes using experimental constraints. AAPS J. (in press).en_US
dc.identifier.citedreferenceMosberg, H.I., Kroona, H.B., Omnaas, J.R., Sobczyk-Kojiro, K., Bush, P. & Mousigian, C. ( 1994 ) Cyclic deltorphin analogs with high delta opioid receptor affinity and selectivity. In: Peptides: Chemistry, Structure and Biology. Proceedings of the 13th American Peptide Symposium ( Hodges, R.S. & Smith, J.A., eds ), pp. 514 – 516. ESCOM, Leiden, the Netherlands.en_US
dc.identifier.citedreferenceZhao, G.-M., Qian, X., Schiller, P.W. & Szeto, H.H. ( 2003 ) Comparison of [Dmt 1 ]DALDA and DAMGO in binding and G protein activation at Μ, δ, and Κ opioid receptors. J. Pharmacol. Exp. Ther. 307, 947 – 954.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1399-3011.2005.00295.x.pdf
Size:
260.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.